Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

A MUM has revealed the surprising side benefit of using skinny jabs – and it’s proved just as life-changing as shedding 7st. Emma Clark, from Hamilton, Lanarkshire, started using ...

Adults with obesity who used medication and received guidance on resistance training and nutrition lost substantially more ...

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

A DAILY weight loss pill that works like Ozempic has succeeded in a major clinical trial. Patients lost an average of a stone and two pounds (7.3kg) each over 10 months. Unhealthy blood sugar ...

Eli Lilly said its drugs showed no signs of live injury in the trial. This is welcome news for researchers after Pfizer ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.